CoChat

Effects of Fatty Acid Therapy in Addition to Strong Statin on Coronary Plaques in Acute Coronary Syndrome: An Optical Coherence Tomography Study

Open access
Kita, Yoko, Watanabe, Makoto, Kamon, Daisuke, Ueda, Tomoya, Soeda, Tsunenari, Okayama, Satoshi, Ishigami, Kenichi, Kawata, Hiroyuki, Horii, Manabu, Inoue, Fumitaka, Doi, Naofumi, Okura, Hiroyuki, Uemura, Shiro, Saito, Yoshihiko · 2020 · Journal of the American Heart Association
Cited by 36

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Vascular healing response associated with adjunctive n‐3 polyunsaturated fatty acid therapy therapy in patients receiving strong statin therapy remains unclear. The aim of this study was to evaluate the effect of polyunsaturated fatty acid therapy with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) in addition to strong statin therapy on coronary atherosclerotic plaques using optical coherence tomography. METHODS AND RESULTS: This prospective multicenter randomized controlled trial included 130 patients with acute coronary syndrome treated with strong statins. They were assigned to either statin only (control group, n=42), statin+high‐dose EPA (1800 mg/day) (EPA group, n=40), statin+EPA (930 mg/day)+DHA (750 mg/day) (EPA+DHA group, n=48). Optical coherence tomography was performed at baseline and at the 8‐month follow‐up. The target for optical coherence tomography analysis was a nonculprit lesion with a lipid plaque. Between baseline and the 8‐month follow‐up, fibrous cap thickness (FCT) significantly increased in all 3 groups. There were no significant differences in the percent change for minimum FCT between the EPA or EPA+DHA group and the control group. In patients with FCT <120 µm (median value), the percent change for minimum FCT was significantly higher in the EPA or EPA+DHA group compared with the control group. CONCLUSIONS: EPA or EPA+DHA therapy in addition to strong statin therapy did not significantly increase FCT in nonculprit plaques compared with strong statin therapy alone, but significantly increased FCT in patients with thinner FCT. Registration: URL: https://www.umin.ac.jp/ctr/ ; Unique identifier: UMIN 000012825.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/jaha.119.015593

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. 10.1016/j.jacc.2004.03.046 · DOI · Paper page
  2. 10.1016/S0140-6736(07)60527-3 · DOI · Paper page
  3. 10.1161/01.ATV.20.5.1262 · DOI · Paper page
  4. 10.1056/NEJMoa1002358 · DOI · Paper page
  5. 10.1001/jama.291.9.1071 · DOI · Paper page
  6. 10.1016/j.jacc.2014.08.045 · DOI · Paper page
  7. 10.1161/01.CIR.0000159354.43778.69 · DOI · Paper page
  8. 10.5551/jat.15867 · DOI
  9. 10.1097/MCA.0000000000000091 · doi:10.1097/mca.0000000000000091
  10. 10.1016/j.jacc.2011.09.079 · DOI · Paper page
  11. 10.1016/j.jacc.2016.10.028 · DOI
  12. 10.1161/CIRCIMAGING.112.973701 · DOI · Paper page
  13. 10.1016/j.atherosclerosis.2008.05.014 · DOI · Paper page
  14. 10.1093/eurheartj/ehz455 · DOI · Paper page
  15. 10.1016/S0140-6736(05)67394-1 · DOI · Paper page
  16. 10.1016/S0140-6736(99)07072-5 · DOI · Paper page
  17. 10.1161/01.CIR.89.1.36 · DOI · Paper page
  18. 10.1161/01.CIR.103.25.3062 · DOI
  19. 10.1016/j.atherosclerosis.2007.07.023 · DOI
  20. 10.1007/s11745-002-0962-7 · DOI
  21. 10.1002/clc.23185 · DOI
  22. 10.1253/circj.CJ-07-0936 · DOI
  23. 10.1194/jlr.P600005-JLR200 · DOI · Paper page
  24. 10.1186/1475-2840-13-13 · DOI
  25. 10.1016/j.atherosclerosis.2016.10.002 · DOI
  26. 10.1016/j.amjcard.2019.02.020 · DOI

Cited by

See all 36

Metadata

Authors
Kita, Y., Watanabe, M., Kamon, D., Ueda, T., Soeda, T., Okayama, S., Ishigami, K., Kawata, H., Horii, M., Inoue, F., Doi, N., Okura, H., Uemura, S., & Saito, Y.
Venue
Journal of the American Heart Association
Published
2020-08-18
Volume
9
Issue
16
Pages
e015593-e015593
ISSN
2047-9980 (ISSN-L)
OpenAlex
W3046365019
Cited by
36
References
12
FWCI
3.40
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.